Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19

J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929.

¹ Feinstein Institutes for Medical Research and The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, NY, USA.
² Departments of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC, USA.
³ Department of Medicine and Surgery, University of Insubria, Varese, Italy.
⁴ Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁵ Thrombosis and Haemophilia Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁶ Department of Emergency and Disaster Medicine, Juntendo University, Tokyo, Japan.
⁷ Department of Medicine and Cardiometabolic Programme-NIHR UCLH/UCL BRC, University College London Hospitals NHS Foundation Trust, London, UK.
⁸ Department of Anaesthesia, Intensive Care and Perioperative Medicine GHU AP-HP. Centre-Université de Paris-Cochin Hospital, Paris, France.
⁹ Department of Haematology, Manchester University Hospitals, Manchester, UK.
¹⁰ Feinstein Institutes for Medical Research, Manhasset, NY, USA.
¹¹ Department of Medicine, McMaster University, Hamilton, ON, Canada.

No abstract available

Keywords: SARS-CoV-2; anticoagulant; antithrombotic therapy; coronavirus disease 2019; hospitalization.

Publication types